These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 3997065

  • 1. Effects of chronic bromocriptine treatment of an estrone-induced, prolactin-secreting rat pituitary adenoma.
    Eljarmak D, Lis M, Cantin M, Carrière PD, Collu R.
    Horm Res; 1985; 21(3):160-7. PubMed ID: 3997065
    [Abstract] [Full Text] [Related]

  • 2. Presence of high affinity dopamine receptors in estrone-induced, prolactin-secreting rat pituitary adenomas: a model for human prolactinomas.
    Eljarmak D, Marchisio AM, Lis M, Collu R.
    Horm Res; 1985; 21(2):107-16. PubMed ID: 3920132
    [Abstract] [Full Text] [Related]

  • 3. Prolactin secretion after surgery or bromocriptine treatment of prolactinoma.
    De Leo V, Petraglia F, Sardelli S, Danero S, Genazzani AR, D'Antona N.
    Obstet Gynecol; 1987 Jan; 69(1):99-103. PubMed ID: 3099236
    [Abstract] [Full Text] [Related]

  • 4. [Pathological changes of prolactinomas treated with bromocriptine].
    Teramoto A, Takakura K, Fukushima T, Osamura Y.
    No Shinkei Geka; 1982 Jun; 10(6):619-27. PubMed ID: 7121729
    [Abstract] [Full Text] [Related]

  • 5. Clinical and pathological effects of bromocriptine on prolactin-secreting and other pituitary tumors.
    Barrow DL, Tindall GT, Kovacs K, Thorner MO, Horvath E, Hoffman JC.
    J Neurosurg; 1984 Jan; 60(1):1-7. PubMed ID: 6689702
    [Abstract] [Full Text] [Related]

  • 6. Estrone-induced, prolactin-secreting and dopamine-sensitive rat pituitary tumor.
    Lis M, Cantin M, Marchisio AM, Eljarmak D, Collu R.
    Eur J Cancer Clin Oncol; 1984 Jun; 20(6):829-39. PubMed ID: 6540183
    [Abstract] [Full Text] [Related]

  • 7. Effect of bromocriptine treatment on the fibrous tissue content of prolactin-secreting and nonfunctioning macroadenomas of the pituitary gland.
    Esiri MM, Bevan JS, Burke CW, Adams CB.
    J Clin Endocrinol Metab; 1986 Aug; 63(2):383-8. PubMed ID: 3722328
    [Abstract] [Full Text] [Related]

  • 8. Resistance to bromocriptine in prolactinomas.
    Pellegrini I, Rasolonjanahary R, Gunz G, Bertrand P, Delivet S, Jedynak CP, Kordon C, Peillon F, Jaquet P, Enjalbert A.
    J Clin Endocrinol Metab; 1989 Sep; 69(3):500-9. PubMed ID: 2760167
    [Abstract] [Full Text] [Related]

  • 9. Antitumor effect of bromocriptine on estrogen-induced rat prolactinomas: ultrastructural alterations of secretory granules.
    Saitoh Y, Koizumi K, Arita N, Hayakawa T, Mogami H, Matsumoto K, Mori H.
    Anticancer Res; 1986 Sep; 6(5):1149-55. PubMed ID: 3800323
    [Abstract] [Full Text] [Related]

  • 10. The effect of tamoxifen on GH and PRL secretion by human pituitary tumors.
    Lamberts SW, de Quijada M, Klijn JG.
    J Endocrinol Invest; 1980 Sep; 3(4):343-7. PubMed ID: 7204884
    [Abstract] [Full Text] [Related]

  • 11. G proteins in normal rat pituitaries and in prolactin-secreting rat pituitary tumors.
    Bouvier C, Forget H, Lagacé G, Drews R, Sinnett D, Labuda D, Collu R.
    Mol Cell Endocrinol; 1991 Jun; 78(1-2):33-44. PubMed ID: 1657658
    [Abstract] [Full Text] [Related]

  • 12. [Medical treatment of prolactin-secreting pituitary adenomas. Influence of the size of the adenoma].
    Kuhn JM, Gancel A, Weinstein A, Courtois H, Schrub JC, Tadie M, Wolf LM.
    Presse Med; 1985 Mar 02; 14(9):525-8. PubMed ID: 3157164
    [Abstract] [Full Text] [Related]

  • 13. Dopamine receptor D2S gene transfer improves the sensitivity of GH3 rat pituitary adenoma cells to bromocriptine.
    Li Q, Su Z, Liu J, Cai L, Lu J, Lin S, Xiong Z, Li W, Zheng W, Wu J, Zhuge Q, Wu Z.
    Mol Cell Endocrinol; 2014 Jan 25; 382(1):377-384. PubMed ID: 24184771
    [Abstract] [Full Text] [Related]

  • 14. Effect of tamoxifen administration on prolactin release by invasive prolactin-secreting pituitary adenomas.
    Lamberts SW, Verleun T, Oosterom R.
    Neuroendocrinology; 1982 Jan 25; 34(5):339-42. PubMed ID: 7078703
    [Abstract] [Full Text] [Related]

  • 15. Time course of induction of prolactin-secreting pituitary tumors with diethylstilbestrol in male rats: response of tuberoinfundibular dopaminergic neurons.
    Morgan WW, Steger RW, Smith MS, Bartke A, Sweeney CA.
    Endocrinology; 1985 Jan 25; 116(1):17-24. PubMed ID: 3917247
    [Abstract] [Full Text] [Related]

  • 16. Tissue kallikrein and the effect of bromocriptine in human prolactin and growth hormone-secreting pituitary adenomas.
    Jones TH, Figueroa CD, Smith CM, Bhoola KD.
    Agents Actions Suppl; 1992 Jan 25; 38 ( Pt 2)():175-82. PubMed ID: 1462825
    [Abstract] [Full Text] [Related]

  • 17. Spontaneous sparsely-granulated prolactin-producing pituitary adenomas in aging rats. A prospective study of the effect of bromocriptine.
    McComb DJ, Hellmann P, Kovacs K, Scott D, Evans WS, Burdman JA, Thorner MO.
    Neuroendocrinology; 1985 Sep 25; 41(3):201-11. PubMed ID: 4047338
    [Abstract] [Full Text] [Related]

  • 18. Ultrastructural localization of prolactin in estrogen-induced prolactinoma of the rat pituitary. Experimental models for the human prolactinomas and the effects of bromocriptine.
    Osamura RY, Watanabe K.
    Acta Pathol Jpn; 1986 Aug 25; 36(8):1131-7. PubMed ID: 3776530
    [Abstract] [Full Text] [Related]

  • 19. Hormonal regulation of prolactin release by human prolactinoma cells cultured in serum-free conditions.
    Jaquet P, Gunz G, Grisoli F.
    Horm Res; 1985 Aug 25; 22(3):153-63. PubMed ID: 3932176
    [Abstract] [Full Text] [Related]

  • 20. Dopamine receptors in rat pituitary and estradiol-induced pituitary tumor: effect of chronic treatment with bromocriptine.
    Di Paolo T, Falardeau P.
    Biochem Biophys Res Commun; 1984 Aug 30; 123(1):312-6. PubMed ID: 6477585
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.